From Live Cells to Insights:
Nanolive’s Next-Gen Immune Profiling Solution
Immunotherapy has transformed the cancer treatment landscape, introducing a wide range of approaches that aim to enhance the immune system’s ability to recognize and eliminate cancer cells. From cell therapies such as CAR-T and TCR-T, to antibody-based treatments, including immune checkpoint inhibitors and bispecific antibodies, the field holds immense promise. Realizing this potential, however, requires more advanced in vitro technologies to accelerate and optimize preclinical development.
Early-stage research and development still lack tools that can accurately and dynamically assess immune cell function and potency.
Existing technologies such as flow cytometry and fluorescence-based imaging often rely on endpoint measurements and fluorescent labelling, limiting real-time functional insights and introducing bias from phototoxicity. To address these limitations, Nanolive’s label-free technology offers a non-invasive solution for studying therapeutic efficacy and potency in real-time.
Watch the release of Nanolive’s next generation immunotherapy solution: the LIVE T Cell Assay. This real-time digital assay combines label-free live cell imaging and AI-powered analysis to deliver continuous, multiparametric data—ranging from T cell activation to target cell interactions and killing.
In this webinar, we will showcase the versatility of the LIVE T Cell Assay through case studies featuring CAR-T and bispecific antibody screening, highlighting the assay’s ability to characterize immunotherapeutic specificity, robustness, and efficacy, as well as its value across different stages of preclinical research and development.
This online event is ideal for scientists in immuno-oncology who are looking to:
- Gain deeper insights into immune cell behavior and cell:cell interactions
- Accelerate screening and candidate selection with high-content data
- Eliminate phototoxicity in sensitive cells and preserve their natural behavior
- Get dynamic, real-time data, moving beyond the limits of endpoint assays
- Streamline workflows, reduce hands-on time, and increase reproducibility with automated analysis
- Support more informed, unbiased decision-making with label-free data
Host
Natasha Szombathy
Global Marketing Manager, Nanolive